Occudo Quantitative Strategies LP Design Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.27 - $4.03 $25,131 - $44,616	11,071 Added 89.83%	23,395 $94,000
Q4 2023 Feb 14, 2024	SELL	$1.99 - $2.76 $175,912 - $243,978	-88,398 Reduced 87.76%	12,324 $32,000
Q3 2023 Nov 14, 2023	BUY	$2.05 - $8.14 $206,480 - $819,877	100,722 New	100,722 $237,000
Q1 2023 May 15, 2023	BUY	$5.5 - $9.77 $69,586 - $123,610	12,652 New	12,652 $73,000

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $324M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.